{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:32:23Z","timestamp":1767846743091,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T00:00:00Z","timestamp":1486166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10549-017-4127-6","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T02:22:27Z","timestamp":1486174947000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Aspirin use is associated with lower mammographic density in a large screening cohort"],"prefix":"10.1007","volume":"162","author":[{"given":"Marie E.","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Oustimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie B.","family":"Synnstvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Cuke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily F.","family":"Conant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"issue":"18","key":"4127_CR1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371\u20131388","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"4127_CR2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381\u20132391","journal-title":"N Engl J Med"},{"issue":"9922","key":"4127_CR3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","volume":"383","author":"J Cuzick","year":"2014","unstructured":"Cuzick J et al (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 383(9922):1041\u20131048","journal-title":"Lancet"},{"issue":"2","key":"4127_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-011-1351-3","volume":"126","author":"SF Dent","year":"2011","unstructured":"Dent SF et al (2011) Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res Treat 126(2):295\u2013310","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"4127_CR5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/bjc.2013.116","volume":"108","author":"B Makubate","year":"2013","unstructured":"Makubate B et al (2013) Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer 108(7):1515\u20131524","journal-title":"Br J Cancer"},{"issue":"3","key":"4127_CR6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10549-007-9665-x","volume":"109","author":"A Ready","year":"2008","unstructured":"Ready A et al (2008) NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat 109(3):533\u2013543","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"4127_CR7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/aje\/kwm216","volume":"166","author":"VA Kirsh","year":"2007","unstructured":"Kirsh VA et al (2007) Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol 166(6):709\u2013716","journal-title":"Am J Epidemiol"},{"issue":"5","key":"4127_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","volume":"9","author":"MJ Thun","year":"2012","unstructured":"Thun MJ, Jacobs EJ, Patrono C (2012) The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9(5):259\u2013267","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4127_CR9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C et al (2012) Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 23(6):1403\u20131415","journal-title":"Ann Oncol"},{"issue":"5","key":"4127_CR10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra AM, Rothwell PM (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13(5):518\u2013527","journal-title":"Lancet Oncol"},{"issue":"8039","key":"4127_CR11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0140-6736(77)92496-5","volume":"2","author":"A Bennett","year":"1977","unstructured":"Bennett A et al (1977) Prostaglandins and breast cancer. Lancet 2(8039):624\u2013626","journal-title":"Lancet"},{"issue":"4B","key":"4127_CR12","first-page":"2997","volume":"19","author":"C Sotiriou","year":"1999","unstructured":"Sotiriou C et al (1999) The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. Anticancer Res 19(4B):2997\u20133006","journal-title":"Anticancer Res"},{"issue":"5","key":"4127_CR13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ijc.1397","volume":"93","author":"N Kundu","year":"2001","unstructured":"Kundu N et al (2001) Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer 93(5):681\u2013686","journal-title":"Int J Cancer"},{"issue":"2","key":"4127_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1503","volume":"17","author":"S Mangiapane","year":"2008","unstructured":"Mangiapane S, Blettner M, Schlattmann P (2008) Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf 17(2):115\u2013124","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"4127_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-011-1747-0","volume":"131","author":"T Luo","year":"2012","unstructured":"Luo T et al (2012) Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 131(2):581\u2013587","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4127_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-010-1074-x","volume":"126","author":"A Bardia","year":"2011","unstructured":"Bardia A et al (2011) Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 126(1):149\u2013155","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"4127_CR17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10552-011-9769-9","volume":"22","author":"TM Brasky","year":"2011","unstructured":"Brasky TM et al (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22(7):965\u2013975","journal-title":"Cancer Causes Control"},{"key":"4127_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2407-5-159","volume":"5","author":"E Rahme","year":"2005","unstructured":"Rahme E et al (2005) Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5:159","journal-title":"BMC Cancer"},{"issue":"18","key":"4127_CR19","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women\u2019s Health Initiative. Cancer Res 63(18):6096\u20136101","journal-title":"Cancer Res"},{"issue":"9826","key":"4127_CR20","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM et al (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379(9826):1602\u20131612","journal-title":"Lancet"},{"issue":"2","key":"4127_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","volume":"159","author":"NR Cook","year":"2013","unstructured":"Cook NR et al (2013) Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med 159(2):77\u201385","journal-title":"Ann Intern Med"},{"issue":"5","key":"4127_CR22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604240","volume":"98","author":"SM Zhang","year":"2008","unstructured":"Zhang SM et al (2008) Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial. Br J Cancer 98(5):989\u2013991","journal-title":"Br J Cancer"},{"issue":"7","key":"4127_CR23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cncr.21763","volume":"106","author":"L Gallicchio","year":"2006","unstructured":"Gallicchio L et al (2006) Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer 106(7):1443\u20131452","journal-title":"Cancer"},{"issue":"15","key":"4127_CR24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/jnci\/84.15.1170","volume":"84","author":"NF Boyd","year":"1992","unstructured":"Boyd NF et al (1992) Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst 84(15):1170\u20131179","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"4127_CR25","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00008469-199802001-00010","volume":"7","author":"M Yaffe","year":"1998","unstructured":"Yaffe M et al (1998) Breast cancer risk and measured mammographic density. Eur J Cancer Prev 7(Suppl 1):S47\u2013S55","journal-title":"Eur J Cancer Prev"},{"issue":"16","key":"4127_CR26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jnci\/91.16.1404","volume":"91","author":"NF Boyd","year":"1999","unstructured":"Boyd NF et al (1999) Mammographic densities and risk of breast cancer among subjects with a family history of this disease. J Natl Cancer Inst 91(16):1404\u20131408","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4127_CR27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11912-001-0083-7","volume":"3","author":"NF Boyd","year":"2001","unstructured":"Boyd NF et al (2001) Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 3(4):314\u2013321","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"4127_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1097-0142(20000715)89:2<369::AID-CNCR23>3.0.CO;2-J","volume":"89","author":"PB Lam","year":"2000","unstructured":"Lam PB et al (2000) The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont. Cancer 89(2):369\u2013375","journal-title":"Cancer"},{"issue":"3","key":"4127_CR29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1076-6332(03)80373-2","volume":"9","author":"JJ Heine","year":"2002","unstructured":"Heine JJ, Malhotra P (2002) Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 1. Tissue and related risk factors. Acad Radiol 9(3):298\u2013316","journal-title":"Acad Radiol"},{"issue":"10","key":"4127_CR30","first-page":"863","volume":"8","author":"C Atkinson","year":"1999","unstructured":"Atkinson C et al (1999) Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomark Prev 8(10):863\u2013866","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"4127_CR31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","volume":"87","author":"NF Boyd","year":"1995","unstructured":"Boyd NF et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670\u2013675","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4127_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiol.2301020870","volume":"230","author":"JA Harvey","year":"2004","unstructured":"Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230(1):29\u201341","journal-title":"Radiology"},{"issue":"1","key":"4127_CR33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0960-9776(02)00212-6","volume":"12","author":"J Warwick","year":"2003","unstructured":"Warwick J et al (2003) Breast density and breast cancer risk factors in a high-risk population. Breast 12(1):10\u201316","journal-title":"Breast"},{"issue":"1","key":"4127_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1054\/bjoc.2000.1151","volume":"83","author":"E Sala","year":"2000","unstructured":"Sala E et al (2000) High risk mammographic parenchymal patterns and diet: a case-control study. Br J Cancer 83(1):121\u2013126","journal-title":"Br J Cancer"},{"issue":"5","key":"4127_CR35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0899-7071(01)00329-1","volume":"25","author":"O Konez","year":"2001","unstructured":"Konez O, Goyal M, Reaven RE (2001) Can tamoxifen cause a significant mammographic density change in breast parenchyma? Clin Imaging 25(5):303\u2013308","journal-title":"Clin Imaging"},{"issue":"9","key":"4127_CR36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/jnci\/djr079","volume":"103","author":"J Cuzick","year":"2011","unstructured":"Cuzick J et al (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103(9):744\u2013752","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"4127_CR37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008469-199912000-00006","volume":"8","author":"CH Gils van","year":"1999","unstructured":"van Gils CH et al (1999) Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev 8(6):509\u2013515","journal-title":"Eur J Cancer Prev"},{"key":"4127_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju425","author":"SJ Nyante","year":"2015","unstructured":"Nyante SJ et al (2015) Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. J Natl Cancer Inst. doi: 10.1093\/jnci\/dju425","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"4127_CR39","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/ijc.28825","volume":"135","author":"ME Work","year":"2014","unstructured":"Work ME et al (2014) Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer. Int J Cancer 135(7):1740\u20131744","journal-title":"Int J Cancer"},{"issue":"12","key":"4127_CR40","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1158\/1055-9965.2090.13.12","volume":"13","author":"E Ziv","year":"2004","unstructured":"Ziv E et al (2004) Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 13(12):2090\u20132095","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"4127_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-007-9829-8","volume":"112","author":"G Maskarinec","year":"2008","unstructured":"Maskarinec G et al (2008) Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density. Breast Cancer Res Treat 112(1):133\u2013139","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4127_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10549-011-1834-2","volume":"132","author":"J Stone","year":"2012","unstructured":"Stone J et al (2012) The association between mammographic density measures and aspirin or other NSAID use. Breast Cancer Res Treat 132(1):259\u2013266","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"4127_CR43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1055-9965.EPI-07-2836","volume":"17","author":"MB Terry","year":"2008","unstructured":"Terry MB et al (2008) Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(5):1088\u20131095","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"4127_CR44","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/1055-9965.EPI-08-1088","volume":"18","author":"A McTiernan","year":"2009","unstructured":"McTiernan A et al (2009) No effect of aspirin on mammographic density in a randomized controlled clinical trial. Cancer Epidemiol Biomarkers Prev 18(5):1524\u20131530","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"4127_CR45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejrad.2006.08.033","volume":"61","author":"C Balleyguier","year":"2007","unstructured":"Balleyguier C et al (2007) BIRADS classification in mammography. Eur J Radiol 61(2):192\u2013194","journal-title":"Eur J Radiol"},{"key":"4127_CR46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12885-015-1979-1","volume":"15","author":"S Kim","year":"2015","unstructured":"Kim S et al (2015) Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer. BMC Cancer 15:960","journal-title":"BMC Cancer"},{"key":"4127_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju255","author":"BL Sprague","year":"2014","unstructured":"Sprague BL et al (2014) Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. doi: 10.1093\/jnci\/dju255","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"4127_CR48","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/jnci\/djq239","volume":"102","author":"NF Boyd","year":"2010","unstructured":"Boyd NF et al (2010) Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 102(16):1224\u20131237","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4127_CR49","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2214\/AJR.06.0619","volume":"188","author":"MG Carmen del","year":"2007","unstructured":"del Carmen MG et al (2007) Mammographic breast density and race. Am J Roentgenol 188(4):1147\u20131150","journal-title":"Am J Roentgenol"},{"issue":"7","key":"4127_CR50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/A:1008926607428","volume":"11","author":"CM Vachon","year":"2000","unstructured":"Vachon CM et al (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11(7):653\u2013662","journal-title":"Cancer Causes Control"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4127-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T13:14:55Z","timestamp":1658582095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4127-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["4127"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4127-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,4]]}}}